Follow
Yugendar Reddy Alugubelli
Yugendar Reddy Alugubelli
Verified email at tamu.edu
Title
Cited by
Cited by
Year
A quick route to multiple highly potent SARS‐CoV‐2 main protease inhibitors
KS Yang, XR Ma, Y Ma, YR Alugubelli, DA Scott, EC Vatansever, ...
ChemMedChem 16 (6), 942-948, 2021
1032021
MPI8 is potent against SARS‐CoV‐2 by inhibiting dually and selectively the SARS‐CoV‐2 main protease and the host cathepsin L
XR Ma, YR Alugubelli, Y Ma, EC Vatansever, DA Scott, Y Qiao, G Yu, ...
ChemMedChem 17 (1), e202100456, 2022
612022
Evaluation of SARS-CoV-2 main protease inhibitors using a novel cell-based assay
W Cao, CCD Cho, ZZ Geng, N Shaabani, XR Ma, EC Vatansever, ...
ACS central science 8 (2), 192-204, 2022
352022
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals
Y Ma, KS Yang, ZZ Geng, YR Alugubelli, N Shaabani, EC Vatansever, ...
European Journal of Medicinal Chemistry 240, 114570, 2022
312022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals
YR Alugubelli, ZZ Geng, KS Yang, N Shaabani, K Khatua, XR Ma, ...
European Journal of Medicinal Chemistry 240, 114596, 2022
262022
First stereoselective total synthesis of seimatopolide A
G Sabitha, AY Reddy, JS Yadav
Tetrahedron Letters 53 (42), 5624-5626, 2012
112012
First total synthesis of antimalarial (+)-cryptorigidifoliol A
A Raju, AY Reddy, G Sabitha
Tetrahedron letters 56 (40), 5474-5476, 2015
92015
A systematic survey of reversibly covalent dipeptidyl inhibitors of the SARS-CoV-2 main protease
ZZ Geng, S Atla, N Shaabani, V Vulupala, KS Yang, YR Alugubelli, ...
Journal of Medicinal Chemistry 66 (16), 11040-11055, 2023
82023
Novel regioselective approach to cyclize phage-displayed peptides in combination with epitope-directed selection to identify a potent neutralizing macrocyclic peptide for SARS …
JT Hampton, TJ Lalonde, JM Tharp, Y Kurra, YR Alugubelli, CM Roundy, ...
ACS chemical biology 17 (10), 2911-2922, 2022
82022
Cellular activities of SARS-CoV-2 main protease inhibitors reveal their unique characteristics
W Cao, CCD Cho, ZZ Geng, XR Ma, R Allen, N Shaabani, EC Vatansever, ...
bioRxiv, 2021.06. 08.447613, 2021
72021
Total Synthesis of Antifungal Macrolide Sch 725674
Y Reddy, G Sabitha
ChemistrySelect 1 (10), 2156-2158, 2016
72016
The N-Terminal Carbamate is Key to High Cellular and Antiviral Potency for Boceprevir-Based SARS-CoV-2 Main Protease Inhibitors
YR Alugubelli, ZZ Geng, KS Yang, N Shaabani, K Khatua, XR Ma, ...
BioRxiv, 2021.12. 18.473330, 2021
52021
Palladium Hydroxide Catalyzed Transformation of Primary Propargylic Alcohols into Aldehydes: Application to the Synthesis of the Tetrahydrofuran Core
G Sabitha, AY Reddy, S Nayak, JS Yadav
Synthesis 44 (11), 1657-1662, 2012
52012
The P3 O-Tert-Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease Inhibitors
Y Ma, KS Yang, ZZ Geng, YR Alugubelli, N Shaabani, EC Vatansever, ...
bioRxiv, 2021.12. 18.473326, 2021
42021
A speedy route to multiple highly potent SARS-CoV-2 main protease inhibitors
KS Yang, XR Ma, Y Ma, YR Alugubelli, DA Scott, EC Vatansever, ...
bioRxiv, 2020.07. 28.223784, 2020
42020
Phage‐assisted, active site‐directed ligand evolution of a potent and selective histone deacetylase 8 inhibitor
JS Morse, YJ Sheng, JT Hampton, LD Sylvain, S Das, YR Alugubelli, ...
Protein science 31 (12), e4512, 2022
32022
Stereoselective Total Synthesis of Macrolide Sch-725674 and C-7-epi-Sch-725674
K Baikadi, A Talakokkula, AV Narsaiah
SynOpen 3 (01), 26-35, 2019
32019
Discovery of first-in-class PROTAC degraders of SARS-CoV-2 main protease
YR Alugubelli, J Xiao, K Khatua, S Kumar, L Sun, Y Ma, XR Ma, ...
Journal of Medicinal Chemistry, 2024
22024
Sars-cov-2 main protease inhibitors
W Liu, CA Fierke, S Xu, K Yang, X Ma, MA Yuying, YR Alugubelli, ...
US Patent App. 17/719,870, 2022
22022
Stereoselective Synthesis of the Revised Structure of γ-Lactone Polyketide from Diaporthe sp. SXZ-19 and Its C-8 Epimer
KSN Reddy, AY Reddy, G Sabitha
Synthesis 48 (21), 3812-3820, 2016
22016
The system can't perform the operation now. Try again later.
Articles 1–20